Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lisa-Maria Kulmer has a total of 24 co-authors. Here are the top co-authors by number of shared publications:

  • Pavlos G. Doulidis

    Clinical Unit of Internal Medicine Small Animals, Department for Companion Animals and Horses, University of Veterinary Medicine, Vienna, Austria

    4 shared publications
  • Nicole Luckschander-Zeller

    Department for Companion Animals and Horses, Clinical Unit of Small Animals Internal Medicine, University of Veterinary Medicine Vienna, Austria

    3 shared publications
  • Iwan Anton Burgener

    Clinical Unit of Small Animals Internal Medicine, Department for Companion Animals and Horses, University of Veterinary Medicine Vienna, 1210 Vienna, Austria

    2 shared publications
  • Verena Steiner

    Tierklinik Sattledt, Traunkreis VET Clinic, Sattledt, Austria

    2 shared publications
  • Alexandro Rodríguez-Rojas

    Clinical Department for Small Animals and Horses, Division of Small Animal Internal Medicine, University of Veterinary Medicine, 1210 Vienna, Austria

    1 shared publication
  • Anda Rosu

    Department for Companion Animals, Small Animal Internal Medicine, University of Veterinary Medicine, Vienna, Austria

    1 shared publication

Latest Publications

  • Open Access

    Clinical Findings, Treatment and Long-Term Outcome in 37 Cats with Non-Associative Immune-Mediated Hemolytic Anemia: A Retrospective Observational Study of Two Treatment Cohorts

    by Lisa-Maria Kulmer, Pavlos G. Doulidis, Iwan A. Burgener, Nicole Luckschander-Zeller

    Background: Non-associative immune-mediated hemolytic anemia (IMHA) is uncommon in cats and carries substantial mortality. Glucocorticoids are first-line treatment, and cyclosporin A (CsA) is frequently added, but data on the clinical course and long-term outcome are limited. We describe clinical findings, treatment, adverse events and outcome in cats with non-associative IMHA. Methods: In this retrospective observational single-center study (October 2014–October 2024), 37 cats diagnosed by the 2019 ACVIM consensus criteria were included; 15 received prednisolone alone (PG) and 22 prednisolone combined with CsA (CPG), allocated at the clinician’s discretion. Between-cohort comparisons are exploratory. Results: Cats in the CPG cohort presented with more severe anemia. Overall mortality was 24.3%, with all deaths within four weeks; survival to discharge was 13/15 (PG) and 19/22 (CPG). Median follow-up was 50 [8–430] and 70 days [12–330]. Two cats achieved sustained treatment-free remission of 4.2 and 1.9 years. Five cats relapsed, four while receiving ongoing immunosuppression. Conclusions: Most cats survived the acute phase but required prolonged immunosuppression, and sustained treatment-free remission was uncommon. Relapses occurred predominantly during ongoing therapy rather than after discontinuation. Because CsA was used preferentially in more severely affected cats, comparative efficacy cannot be assessed and remains to be addressed prospectively.

  • Open Access

    Point-of-care ClotPro thromboelastography in three Maine Coon cats with factor XI deficiency

    by Lisa-Maria Kulmer, Pavlos G. Doulidis, Verena Steiner, Nicole Luckschander-Zeller

    Case series summary: Factor XI (FXI) deficiency is a hereditary autosomal recessive coagulation disorder recently identified in Maine Coon cats. Affected cats typically show markedly prolonged activated partial thromboplastin time (aPTT), yet the bleeding risk remains unclear. This case series describes three Maine Coon cats homozygous for the F11 variant linked to FXI deficiency and wild type for both known F12 variants. FXI activity was in the range of 15–58% (reference interval 69–134). All three cats exhibited prolonged aPTT, with prolonged intrinsic pathway clotting times in the two cats in which the IN-test could be performed, while clot firmness was preserved in all three. Increased functional fibrinogen test maximum lysis in two cats was of uncertain significance given the use of human reference intervals. Invasive procedures comprised fine-needle aspiration, gastroduodenoscopy with biopsy collection, abdominocentesis and elective ovariohysterectomy, and were performed without haemorrhage, consistent with the variable penetrance of the bleeding tendency reported with this variant rather than evidence that FXI deficiency confers no bleeding risk. Relevance and novel information: This report describes the viscoelastic profile of FXI-deficient cats, in which the intrinsic pathway defect was reflected in markedly prolonged IN-test clotting times with preserved clot firmness. Whether viscoelastic testing can discriminate bleeding risk will require evaluation of affected cats with a documented bleeding phenotype, and feline-specific ClotPro reference intervals will be essential. This study demonstrates the clinical utility of screening Maine Coon cats for hereditary FXI deficiency to aid the interpretation of prolonged clotting times in the aPTT and in viscoelastic screening tests.

  • Open Access

    First autochthonous case of Opisthorchis felineus in Austria

    by Lisa-Maria Kulmer, Maria Sophia Unterköfler, Yasamin Vali, Ilse Schwendenwein, Nicole Luckschander-Zeller

    Background: Opisthorchis felineus is a feline pathogen with zoonotic potential that can be a causative agent of human opisthorchiasis and cholangiocarcinoma. In Europe, O. felineus is particularly endemic in Eastern European countries, while this parasite has also been sporadically detected in Germany, Italy and northern Poland. Parts of Asia, such as Russia, Ukraine and Kazakhstan, are also affected. Methods: A 7-year-old female neutered European Shorthair cat, without any traveling history, presented in May 2023 with weight loss, anorexia and vomiting. Results: The cat showed increased liver enzyme activities, hyperbilirubinemia and hyperammonemia consistent with the suspected diagnosis of cholangitis with consecutive hepatoencephalopathy. Eggs of O. felineus were detected by routine cytological examination of bile smears and PCR confirmed O. felineus. Conclusions: This is the first report of autochthonous O. felineus infection in Austria. Graphical


  • Open Access

    Point-of-care ClotPro thromboelastography to determine bleeding risk in two cats with factor XII deficiency

    by Vera Forer, Pavlos G Doulidis, Verena Steiner, Natali Bauer, Lisa Maria Kulmer, Nicole Luckschander-Zeller

    Case series summary: Factor XII (FXII) deficiency is a rare autosomal recessive genetic disorder in cats, leading to singular prolonged activated partial thromboplastin clotting time (aPTT) without increased bleeding risk. This case series describes two cats diagnosed with FXII deficiency using the ClotPro system, a point-of-care viscoelastic coagulation test. Both cats exhibited significantly prolonged aPTT and intrinsic pathway clotting time but maintained normal clot strength, as indicated by thromboelastography (TEG). FXII deficiency was confirmed through quantitative ELISA measurement. Despite prolonged clotting times, the cats did not demonstrate clinical bleeding, suggesting that FXII deficiency does not increase bleeding risk. However, larger controlled studies are necessary to further investigate the utility of TEG in cats with FXII deficiency or other coagulation disorders. Relevance and novel information: This study addresses the diagnostic challenges associated with FXII deficiency, a condition that can lead to misinterpretation of coagulation results and unnecessary treatments. It highlights the application of the ClotPro system in feline medicine, providing deeper insights into coagulation dynamics and confirming that FXII deficiency does not inherently increase bleeding risk despite prolonged clotting times.


  • Open Access

    Plasma proteome signature of canine acute haemorrhagic diarrhoea syndrome (AHDS)

    by Lukas Huber, Benno Kuropka, Pavlos G. Doulidis, Elisabeth Baszler, Lukas Martin, Anda Rosu, Lisa Kulmer, Carolina Frizzo Ramos, Alexandro Rodríguez-Rojas, Iwan A. Burgener

    Acute haemorrhagic diarrhoea is a common complaint in dogs. In addition to causes like intestinal parasites, dietary indiscretion, intestinal foreign bodies, canine parvovirus infection, or hypoadrenocorticism, acute haemorrhagic diarrhoea syndrome (AHDS) is an important and sometimes life-threatening differential diagnosis. There is some evidence supporting the link between Clostridium perfringens toxins and AHDS. These toxins may be partially responsible for the epithelial cell injury, but the pathogenesis of AHDS is still not fully understood. Recent studies have suggested that severe damage to the intestinal mucosa and associated barrier dysfunction can trigger chronic gastrointestinal illnesses. Besides bloodwork and classical markers for AHDS such as protein loss and intestinal bacterial dysbiosis, we focused mainly on the plasma-proteome to identify systemic pathological alterations during this disease and searched for potential biomarkers to improve the diagnosis. To accomplish the goals, we used liquid chromatography-mass spectrometry. We compared the proteomic profiles of 20 dogs with AHDS to 20 age-, breed-, and sex-matched control dogs. All dogs were examined, and several blood work parameters were determined and compared, including plasma biochemistry and cell counts. We identified and quantified (relative quantification) 207 plasmatic proteins, from which dozens showed significantly altered levels in AHDS. Serpina3, Lipopolysaccharide-binding protein, several Ig-like domain-containing proteins, Glyceraldehyde-3-phosphate dehydrogenase and Serum amyloid A were more abundant in plasma from AHDS affected dogs. In contrast, other proteins such as Paraoxonase, Selenoprotein, Amine oxidases, and Apolipoprotein C-IV were significantly less abundant. Many of the identified and quantified proteins are known to be associated with inflammation. Other proteins like Serpina3 and RPLP1 have a relevant role in oncogenesis. Some proteins and their roles have not yet been described in dogs with diarrhoea. Our study opens new avenues that could contribute to the understanding of the aetiology and pathophysiology of AHDS.


  • Open Access

    First Autochthonous Infection of a Cat with Dirofilaria immitis in Austria

    by Lisa-Maria Kulmer, Maria Sophia Unterköfler, Hans-Peter Fuehrer, Varvara Janovska, Matus Pagac, Michaela Svoboda, Luigi Venco, Michael Leschnik

    This case report is about a seven-year-old male neutered European Shorthair cat infected by Dirofilaria immitis as the first reported autochthonous Dirofilaria immitis infection in Austria. There was no history of periods abroad. Echocardiography showed suspected D. immitis in the right cardiac chamber with increased pulmonary pressure and ascites. Surgical removal of the heartworms was performed. Twenty adult heartworms were removed by transvenous jugular approach under general anesthesia and stored in 4% formalin. Five out of 20 specimens were examined via light and stereomicroscopy and feline heartworm infection was confirmed. Amplification of a 203 bp or 724 bp fragment of the cytochrome c oxidase subunit I gene was unsuccessful. After surgery the cat developed acute renal failure but recovered quickly. One year later, the cat underwent a control examination including echocardiography and blood work. There were no more D. immitis detectable at echocardiography. Lung pressure was mildly increased. Complete blood count and creatinine were unremarkable. The Knott’s test and Dirofilaria-Antigen-test produced negative results. The cat did not show any clinical signs during the follow-up period. The aim of this case report is to highlight the growing risk of acquiring infection with D. immitis not only for Austrian dogs, but also for cats. This case report represents the first report of autochthonous D. immitis infection in Austria. Moreover, even if the prognosis in cats with caval syndrome due to feline heartworm disease is guarded to poor, surgical removal of the filariae can be a successful treatment option.